Bylvay 유럽 연합 - 리투아니아어 - EMA (European Medicines Agency)

bylvay

albireo - odevixibat - cholestasis, intrahepatic - tulžies ir kepenų terapija - bylvay is indicated for the treatment of progressive familial intrahepatic cholestasis (pfic) in patients aged 6 months or older (see sections 4. 4 ir 5.

Formicpro 68,2 g, avilio juostelės naminėms bitėms 리투아니아 - 리투아니아어 - SMCA (Valstybinė vaistų kontrolės tarnyba)

formicpro 68,2 g, avilio juostelės naminėms bitėms

nod apiary ireland ltd. (airija) - avilio juostelė - kiekvienoje avilio juostelėje yra: veikliosios medžiagos skruzdžių rūgšties 68.2g; - naminėms bitėms (apis mellifera), užsikrėtusioms varroa destructor sukelta varoze, gydyti.

Dimethyl fumarate Polpharma 유럽 연합 - 리투아니아어 - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetilfumaratas - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Pemetrexed Baxter 유럽 연합 - 리투아니아어 - EMA (European Medicines Agency)

pemetrexed baxter

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antinavikiniai vaistai - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Mivacron 리투아니아 - 리투아니아어 - SMCA (Valstybinė vaistų kontrolės tarnyba)

mivacron

limedika, uab - mivakurio chloridas - injekcinis ar infuzinis tirpalas - 2 mg/ml - mivacurium chloride

Azzalure 리투아니아 - 리투아니아어 - SMCA (Valstybinė vaistų kontrolės tarnyba)

azzalure

ipsen pharma - botulino toksinas a tipo (clostridium botulinum a tipo toksino ir hemagliutinino kompleksas) - milteliai injekciniam tirpalui - 125 speywood v/0 mg - botulinum toxin